Following the listing of IHH Healthcare (Malaysia) on 25 July 2012, FTSE announces the following changes: | INDEX | CHANGE | EFFECTIVE FROM START OF TRADING | | FTSE Asian Health Care Index | IHH Healthcare (Malaysia , B83X6P8, 5225) will be added to the Index with a shares in issue total of 8,057,080,242 and an investability weighting of 30%.
Glaxosmithkline Pharmaceuticals Ltd (India, 6117982, GLAXO) will be deleted from the Index. | 1 August 2012 |
FREE TRIAL OFFER: FTSE offers free one month index trials to interested clients. For further information or general enquiries please contact us at info@ftse.com or call: | Client Services in UK: | Tel: +44 (0) 20 7866 1810 | | Client Services in Europe, Middle East & Africa: | Tel: +44 (0) 20 7866 1810 | | Client Services in US: | New York: (Domestic) + 1 888 747 FTSE (3873) / (International): +1 212 314 1139 | | Client Services in Asia Pacific: | Tel: +852 2164 3333 or +65 6223 3738 or +81 3 3581 2764 |
Alternatively please visit our website at www.ftse.com |
